Early access schemes for innovative health technologies: the views of international stakeholders.
Int J Technol Assess Health Care
; 39(1): e45, 2023 Jul 06.
Article
em En
| MEDLINE
| ID: mdl-37409515
ABSTRACT
OBJECTIVES:
Early access schemes (EASs) are approaches used by payers to balance and facilitate earlier patient access to innovative health technologies while evidence generation is ongoing. Schemes require investment from payers and are associated with significant risk since not all technologies will be routinely reimbursed. The purpose of this study was to gain the perspectives of policy experts about the key challenges for EASs and potential solutions for their optimal design and implementation.METHODS:
Two virtual workshops were convened including (i) UK-based policy experts (England, Wales, and Scotland) and (ii) representatives from multiple healthcare systems (England, France, Sweden, Canada, Poland, and Norway). Participants were encouraged to share their experiences with EASs in their healthcare system and highlight key challenges for policy makers. Discussions were transcribed and analyzed using framework analysis.RESULTS:
Participants agreed that EASs have value when targeted toward innovative technologies with the potential for significant clinical benefit in an area of high unmet need. Participants discussed potential solutions to the challenges faced by payers implementing EASs, including defining eligibility criteria, supporting evidence generation, and approaches to reimbursement.CONCLUSIONS:
Participants agreed that EASs are one possible solution for their healthcare systems and have the potential to deliver significant clinical value to patients. However, widespread adoption of EASs is limited due to concerns about the risks for patients and healthcare budgets, further solutions are needed to deliver EASs for targeted therapies.Palavras-chave
Texto completo:
1
Eixos temáticos:
Inovacao_tecnologica
Base de dados:
MEDLINE
Assunto principal:
Tecnologia Biomédica
/
Atenção à Saúde
Tipo de estudo:
Health_technology_assessment
Limite:
Humans
País como assunto:
Europa
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article